相关实验视频
Updated: Jul 18, 2025

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
17β-hydroxysteroid脱酶13的脂质滴定位的结构基础
Shenping Liu1, Ruth F Sommese2, Nicole L Nedoma3
1Medicine Design, Pfizer Inc, Groton, CT, 06340, USA. Shenping.Liu@pfizer.com.
在Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13) 中功能变异的丧失可能会防止肝病的进展. 晶体结构揭示了对HSD17B13功能和用于治疗肝病的抑制剂设计的见解.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 水氧类固醇17-β-脱酶13 (HSD17B13) 是一种与脂质滴相关的酶,在非酒精性脂肪肝疾病中被上调.
- 在HSD17B13中功能丧失的变体与对严重肝病的保护有关,包括脂肪肝炎,纤维化和癌症.
研究的目的:
- 为了确定全长HSD17B13的晶体结构.
- 阐明酶与其辅因子,脂质和潜在抑制剂的相互作用.
- 为了解HSD17B13功能和设计新疗法提供结构基础.
主要方法:
- 使用X射线结晶学来获得HSD17B13的结构.
- 确定了酶的结构,包括NAD +,脂质/洗剂分子和两个不同的小分子抑制剂系列.
- 对连接体结合口袋和活性位点相互作用的分析.
主要成果:
- 全长HSD17B13的晶体结构与NAD+和脂质/洗剂分子复合解决.
- 结构揭示了HSD17B13如何通过脂质滴在膜上.
- 两个抑制剂系列以类似的方式与活性部位结合,但通过不同的进入途径,与关键残留物和辅因子相互作用.
结论:
- 确定的结构提供了关于脂质滴相关蛋白质定机制的见解.
- 这些发现为了解HSD17B13变种如何失去功能提供了结构基础.
- 这些结构可以指导基于结构的药物设计,用于针对肝病的新型抑制剂.
更多相关视频
09:41Isolation of Cellular Lipid Droplets: Two Purification Techniques Starting from Yeast Cells and Human Placentas
Published on: April 1, 2014
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
What are Lipids?
Non-Polar and Hydrophobic Characteristics of Lipids
Lipids are a structurally and functionally diverse group of hydrocarbons—compounds consisting of carbon and hydrogen atoms. The carbon-carbon and...
Asymmetric Lipid Bilayer
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Lipid Catabolism
Biosynthesis of Lipids